InvestorsHub Logo
Followers 43
Posts 4314
Boards Moderated 0
Alias Born 09/01/2017

Re: Poor Man - post# 567089

Sunday, 02/12/2023 4:47:10 PM

Sunday, February 12, 2023 4:47:10 PM

Post# of 704572
Here’s my very simplistic analysis:

DCVax-L works and is best treatment available today for GBM

The phase 3 trial validated the efficacy

DCVax is alone in looonnngggg term survivors, bar none

DCVax is safest, most QoL treatment that essentially does no harm

Phase 3 trial proved DCVax can be produced and administered for a large number of geographically dispersed sites and administered doses anywhere like any other vaccine shot in the arm

Downside? NONE!!!!

Decision: doh! Winner winner chicken dinner as obvious as the noses on our faces - it would be criminal to not approve DCVax !!!!

Then peek at combo results and you’d have to be out of your mind or compromised to hold back DCVax!

Imho of course

In summary, you don’t need to be a rocket scientist to see the case for approval and for humanity for the love of God!!!

Clear enough?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News